Target- |
MechanismRNA interference |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Kunshan Riboquark Pharmaceutical Science & Technology Co.
0 Patents (Medical) associated with Kunshan Riboquark Pharmaceutical Science & Technology Co.
100 Deals associated with Kunshan Riboquark Pharmaceutical Science & Technology Co.
100 Translational Medicine associated with Kunshan Riboquark Pharmaceutical Science & Technology Co.